Breaking News Instant updates and real-time market news.

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

09:30
04/25/19
04/25
09:30
04/25/19
09:30

Microsoft price target raised to $145 from $125 at Credit Suisse

Credit Suisse analyst Brad Zelnick raised his price target for Microsoft to $145 from $125, noting that overachievement in high-margin businesses and strong commercial bookings growth along with solid 2020 commentary were the highlights of the quarter. The analyst reiterates an Outperform rating on the shares.

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

MSFT Microsoft
$125.00

-0.5 (-0.40%)

04/25/19
BMOC
04/25/19
NO CHANGE
Target $147
BMOC
Outperform
Microsoft price target raised to $147 from $125 at BMO Capital
BMO Capital analyst Keith Bachman raised his price target on Microsoft to $147 and kept his Outperform rating after its Q3 earnings beat, saying the stock "can move higher" in spite of its recently expanded multiple. The analyst says the latest quarter further highlights the "durability" of Microsoft's business model, adding that the company also has "upside tension" relative to its June quarter guidance.
04/25/19
WEDB
04/25/19
NO CHANGE
Target $155
WEDB
Outperform
Microsoft price target raised to $155 from $150 at Wedbush
Wedbush analyst Daniel Ives raised his price target for Microsoft (MSFT) to $155 from $150 as he sees March results as "another feather in the cap for Nadella in the company's quest to become a cloud behemoth," with Azure growing 73% year over year and continuing to gain share versus the likes of AWS and Amazon (AMZN). Ives is bullish on Microsoft into the rest of 2019/2020 given his thesis that Azure's cloud momentum is still in its early days of playing out with the company's massive installed base, Office 365 transition on consumer/enterprise providing growth tailwinds for the next 12-18 months at least, and newer integrated product initiatives around consumers and cloud services are still playing out. He reiterates an Outperform rating on the shares.
04/25/19
MSCO
04/25/19
NO CHANGE
Target $145
MSCO
Overweight
Morgan Stanley has higher conviction in Microsoft EPS growth after Q3 report
Morgan Stanley analyst Keith Weiss said Microsoft's better than expected Q3 results and management guidance on targeting double-digit growth in FY20 gives him increased conviction in his forecast for 16% EPS CAGR over a 3-year period. Weiss, who said the core of his positive investment thesis on Microsoft remains its strong secular positioning in the commercial businesses, keeps an Overweight rating on the shares and raised his price target to $145 from $140.
04/25/19
OPCO
04/25/19
NO CHANGE
Target $145
OPCO
Outperform
Microsoft price target raised to $145 from $127 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for Microsoft to $145 from $127 as he believes the company's s Hybrid Cloud Business is entering its "sweet spot" of enterprise adoption and operating leverage. The analyst estimates total cloud-based revenue grew 38% to about $10B in the third quarter and expects premium services to continue to drive Azure, which grew 75% year over year. Horan reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

HST

Host Hotels

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Host Hotels initiated  »

Host Hotels initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PK

Park Hotels & Resorts

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Park Hotels & Resorts initiated  »

Park Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEB

Pebblebrook Hotel

$27.31

-1.175 (-4.13%)

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Pebblebrook Hotel initiated  »

Pebblebrook Hotel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLE

Apple Hospitality REIT

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Apple Hospitality REIT initiated  »

Apple Hospitality REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLJ

RLJ Lodging Trust

$17.56

-0.28 (-1.57%)

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
RLJ Lodging Trust initiated  »

RLJ Lodging Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INN

Summit Hotel Properties

$11.30

-0.14 (-1.22%)

06:39
06/25/19
06/25
06:39
06/25/19
06:39
Initiation
Summit Hotel Properties initiated  »

Summit Hotel Properties …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$160.88

-4.43 (-2.68%)

06:35
06/25/19
06/25
06:35
06/25/19
06:35
Periodicals
FedEx sues government over enforcement of China export ban, Reuters reports »

FedEx has sued the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

06:33
06/25/19
06/25
06:33
06/25/19
06:33
Periodicals
AbbVie near deal to buy Allergan for $188 per share in cash and stock, WSJ says »

AbbVie (ABBV) is closing…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

CODX

Co-Diagnostics

$0.74

-0.0295 (-3.86%)

06:33
06/25/19
06/25
06:33
06/25/19
06:33
Hot Stocks
Co-Diagnostics launches Logix Smart ZDC multiplex test »

Co-Diagnostics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BW

Babcock & Wilcox

$0.41

0.0263 (6.85%)

06:32
06/25/19
06/25
06:32
06/25/19
06:32
Hot Stocks
Babcock & Wilcox sells Loibl to subsidiary of Deutsche Invest Mittelstand »

Babcock & Wilcox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CR

Crane

$80.55

-0.18 (-0.22%)

, CIR

Circor

$45.77

-0.03 (-0.07%)

06:32
06/25/19
06/25
06:32
06/25/19
06:32
Hot Stocks
Crane refutes Circor's plan, urges shareholders to tender shares »

Crane (CR) filed a…

CR

Crane

$80.55

-0.18 (-0.22%)

CIR

Circor

$45.77

-0.03 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

06:28
06/25/19
06/25
06:28
06/25/19
06:28
Periodicals
Breaking Periodicals news story on Allergan, AbbVie »

AbbVie would pay $188 per…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

06:27
06/25/19
06/25
06:27
06/25/19
06:27
Periodicals
Breaking Periodicals news story on Allergan, AbbVie »

AbbVie near deal to…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

PT

Pintec Technology

$2.98

-0.13 (-4.18%)

06:27
06/25/19
06/25
06:27
06/25/19
06:27
Hot Stocks
Pintec Technology announces strategic partnership with Bank of Ganzhou »

Pintec Technology inked a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDY

Dr. Reddy's

$36.08

-0.12 (-0.33%)

06:24
06/25/19
06/25
06:24
06/25/19
06:24
Hot Stocks
Dr. Reddy's launches its Tobramycin Inhalation Solution »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$28.91

-0.17 (-0.58%)

06:21
06/25/19
06/25
06:21
06/25/19
06:21
Periodicals
JD.com's logistics unit raises $218M investment fund, Reuters reports »

The logistics division of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$311.63

-15.05 (-4.61%)

06:19
06/25/19
06/25
06:19
06/25/19
06:19
Downgrade
Shopify rating change  »

Shopify downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CBMG

Cellular Biomedicine

$15.01

(0.00%)

06:19
06/25/19
06/25
06:19
06/25/19
06:19
Initiation
Cellular Biomedicine initiated  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$47.63

0.17 (0.36%)

06:18
06/25/19
06/25
06:18
06/25/19
06:18
Periodicals
Intel plans to cut desktop processor prices by up to 15%, DigiTimes reports »

Intel is planning to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

06:15
06/25/19
06/25
06:15
06/25/19
06:15
Periodicals
U.S.: Turkey would lose F-35 if Russia arms deal moves forward, Reuters says »

The U.S. cannot allow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

06:12
06/25/19
06/25
06:12
06/25/19
06:12
Periodicals
Nissan overhauls board following disorderly investor meeting, WSJ reports »

Nissan investors voted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVTL

Pivotal Software

$11.35

-0.15 (-1.30%)

06:11
06/25/19
06/25
06:11
06/25/19
06:11
Downgrade
Pivotal Software rating change  »

Pivotal Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

, GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

06:08
06/25/19
06/25
06:08
06/25/19
06:08
Periodicals
Alphabet's Sidewalk Labs meets resistance over Toronto plans, WSJ reports »

Sidewalk Labs, a unit of…

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

LEN

Lennar

$51.41

0.09 (0.18%)

06:07
06/25/19
06/25
06:07
06/25/19
06:07
Earnings
Lennar reports Q2 EPS $1.30, consensus $1.14 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

BAS

Basic Energy

$2.43

-0.21 (-7.95%)

06:07
06/25/19
06/25
06:07
06/25/19
06:07
Downgrade
Basic Energy rating change  »

Basic Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.